ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water
By Elana Gotkine HealthDay Reporter

WEDNESDAY, June 25, 2025 -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss and T2D remission, according to a study presented at the annual meeting of the American Diabetes Association, held from June 20 to 23 in Chicago.
Mehdi Farshchi, from the University of British Columbia in Vancouver, Canada, and colleagues conducted a single-blind, randomized trial to examine the effects of replacing DBs with water on the durability of weight loss and T2D remission. A total of 81 adult women with overweight or obesity (body mass index 27 to 35 kg/m2) and T2D (glycated hemoglobin 6.5 to 7.2 percent) treated with metformin, were included in the study and completed a six-month weight loss intervention and 12-month weight maintenance program. The patients were randomly assigned to either substitute with water or continue drinking DBs for the 18-month follow-up.
The researchers found that a significant weight change was seen in the water group versus the DB group after the 18-month follow-up period (−6.82 ± 2.73 versus −4.85 ± 2.07 kg). T2D remission was achieved in 90 percent of 41 participants in the water group and 45 percent of 40 participants in the DB group. Compared with the DB group, the water group also had significant changes in body mass index, fasting plasma glucose, insulin levels, the homeostasis model assessment of insulin resistance, two-hour postprandial glucose, and serum triglycerides over the 18 months.
"These findings challenge a common belief in the U.S. that diet drinks have no potential negative effects for managing weight and blood sugar," lead author Hamid R. Farshchi, M.D., Ph.D., chief executive officer of D2Type, said in a statement. "Our study highlights the importance of promoting water, not just low-calorie alternatives, as part of effective diabetes and weight management. It's a small change with the potential for a big impact on long-term health outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-26 06:00
Read more

- Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
- After Dobbs, 42 Percent of Surveyed Abortion Providers in Abortion-Ban States Relocated
- Illinois Reports First West Nile Virus Case of 2025
- New Results for Johnson & Johnson’s Bleximenib Demonstrate Promising Antileukemic Activity in Combination with Venetoclax and Azacitidine for Acute Myeloid Leukemia
- BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma
- Lack Of Sleep Alters Teens' Brains, Potentially Promoting Behavior Issues
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions